CVS analyst estimates

CVS Health (CVS) analyst ratings, the average price target and its range, and every firm's latest call.

CVS analyst ratings and price targets

DateFirmCallTarget
Nov 13, 2026Piper SandlerCVS Health (CVS) PT Lowered to $106 at Bernstein SocGen Group$106.00
Nov 6, 2026Raymond JamesCVS Health (CVS) PT Lowered to $103 at Raymond James$103.00
Nov 4, 2026Bank of America SecuritiesBofA Securities Reiterates Buy Rating on CVS Health (CVS)$110.00
Nov 4, 2026UBSTD Cowen Reiterates Buy Rating on CVS Health (CVS)$110.00
Nov 4, 2026Raymond JamesRaymond James Reiterates Outperform Rating on CVS Health (CVS)$120.00
Nov 4, 2026JefferiesCVS Health (CVS) PT Lowered to $103 at Jefferies$103.00
Oct 12, 2026Leerink PartnersCVS Health price target lowered to $112 from $119 at Leerink$112.00
Sep 9, 2026BMO CapitalCVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group$112.00
Sep 9, 2026BernsteinCVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group$112.00
Sep 9, 2026Piper SandlerCVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group$112.00
Sep 3, 2026UBSCVS Health price target lowered to $118 from $126 at UBS$118.00
Aug 19, 2026Argus ResearchCVS Health price target raised to $114 from $104 at Argus$114.00
Aug 6, 2026BarclaysCVS Health price target raised to $108 from $106 at Barclays$108.00
Aug 6, 2026UBSCVS Health (CVS) PT Raised to $126 at UBS$126.00
Aug 6, 2026Robert W. BairdCVS Health price target raised to $107 from $94 at Baird$107.00